Verizon has acquired short-form video platform Vessel, which had reportedly raised more than $130m from investors including Comcast Ventures.
Stanford has exited open source software-focused cybersecurity company Palamida, which had raised $18.5m in funding, in an acquisition by Flexera Software.
Mitsui has exited open source software-focused cybersecurity company Palamida, which had raised $18.5m in funding, in an acquisition by Flexera Software.
Pfizer, Takeda and BB Biotech invested a combined $88m in the offering, conducted less than five months after Myovant spun out of Roivant Sciences.
Novo, Novartis and Amgen all recorded exits as blood disorder therapeutics developer Ra floated in the middle of its range.
Tute Genomics, a bioinformatics software developer backed by Tencent, Intermountain Healthcare and Wilmington Pharmatech, has been bought for an undisclosed sum.
Proofpoint has agreed to purchase cybersecurity software developer FireLayers in a $55m deal, a year after it closed an Akamai-backed funding round.
The purchase of eye-tracking technology developer Eyefluence for an undisclosed amount has provided an exit to backers including Motorola, Intel and Naver.
Stanford University spinout iRhythm, which had raised a total of $115.5m in equity and debt, has gone public in a $107m initial public offering.
The Novo, St. Jude and Kaiser Permanente-backed cardiac diagnostics technology developer floated above its range and closed its first day of trading 53% up on its IPO price.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
